Comparative Pharmacology
Head-to-head clinical analysis: HEXA BETALIN versus THIAMINE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HEXA BETALIN versus THIAMINE HYDROCHLORIDE.
HEXA-BETALIN vs THIAMINE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hexa-Betalin is a combination of six B vitamins (B1, B2, B3, B5, B6, B12) that act as cofactors in various enzymatic reactions involved in energy metabolism, neurotransmitter synthesis, and nerve function.
Thiamine hydrochloride is a water-soluble vitamin that acts as a cofactor for several enzymes involved in carbohydrate metabolism, including transketolase, pyruvate dehydrogenase, and α-ketoglutarate dehydrogenase. It is essential for the decarboxylation of α-keto acids and pentose phosphate pathway activity.
Dosage forms: Tablet 10mg, 50mg, 100mg, 250mg; Injection 50mg/mL. Usual adult dose: 100–250mg orally 1–3 times daily. Maximum 1000mg/day. IV/IM: 50–250mg every 6–8 hours as needed.
50-100 mg intravenously or intramuscularly once daily for deficiency; 100 mg intravenously for Wernicke encephalopathy (with 50-100 mg maintenance).
None Documented
None Documented
Terminal elimination half-life is approximately 3-5 hours in patients with normal renal function. This short half-life necessitates frequent dosing for sustained therapeutic effect. Half-life is prolonged in renal impairment.
Terminal half-life: 9-18 days for whole body stores; plasma half-life: 1.5-2 hours for free thiamine.
Renal excretion of unchanged drug accounts for 75-85% of the administered dose. Biliary/fecal elimination is minimal, less than 5%.
Renal: 40-50% as unchanged drug; metabolites: thiamine pyrophosphate, thiamine monophosphate. Fecal: minimal (<5%).
Category C
Category C
Vitamin
Vitamin